Lactobacillus rhamnosus Strain GG Reduces Aflatoxin B1 Transport, Metabolism, and Toxicity in Caco-2 Cells

The probiotic Lactobacillus rhamnosus GG is able to bind the potent hepatocarcinogen aflatoxin B₁ (AFB₁) and thus potentially restrict its rapid absorption from the intestine. In this study we investigated the potential of GG to reduce AFB₁ availability in vitro in Caco-2 cells adapted to express cytochrome P-450 (CYP) 3A4, such that both transport and toxicity could be assessed. Caco-2 cells were grown as confluent monolayers on transmembrane filters for 21 days prior to all studies. AFB₁ levels in culture medium were measured by high-performance liquid chromatography. In CYP 3A4-induced monolayers, AFB₁ transport from the apical to the basolateral chamber was reduced from 11.1% ± 1.9% to 6.4% ± 2.5% (P = 0.019) and to 3.3% ± 1.8% (P = 0.002) within the first hour in monolayers coincubated with GG (1 × 10¹⁰ and 5 × 10¹⁰ CFU/ml, respectively). GG (1 × 10¹⁰ and 5 × 10¹⁰ CFU/ml) bound 40.1% ± 8.3% and 61.0% ± 6.0% of added AFB₁ after 1 h, respectively. AFB₁ caused significant reductions of 30.1% (P = 0.01), 49.4% (P = 0.004), and 64.4% (P < 0.001) in transepithelial resistance after 24, 48, and 72 h, respectively. Coincubation with 1 × 10¹⁰ CFU/ml GG after 24 h protected against AFB₁-induced reductions in transepithelial resistance at both 24 h (P = 0.002) and 48 h (P = 0.04). DNA fragmentation was apparent in cells treated only with AFB₁ cells but not in cells coincubated with either 1 × 10¹⁰ or 5 × 10¹⁰ CFU/ml GG. GG reduced AFB₁ uptake and protected against both membrane and DNA damage in the Caco-2 model. These data are suggestive of a beneficial role of GG against dietary exposure to aflatoxin.     

Interrelationships of dietary protein level,aflatoxin B1 metabolism,and hepatic microsomal epoxide hydrase activity

In a continuation of studies on protein intake and aflatoxin B₁ (AFB₁) metabolism, weanling rats were fed semipurified diets containing either 20% casein or 5% casein for two weeks to determine the effect of dietary protein level on hepatic microsomal epoxide hydrase activity and AFB₁ metabolism in an effort to evaluate the role of protein intake on the formation and degradation of the reactive metabolite of AFB₁. Styrene oxide was used as substrate for epoxide hydrase since the hypothetical AFB₁ 2,3-epoxide (AFB-epox) cannot be synthesized because of its lability. Two groups of animals were fed 20% casein diets; one was fed ad libitum and the second was pair fed to the 5% casein group in order to control the effects of total feed intake. The depression of epoxide hydrase activities caused by the 5% casein diets was approximately equivalent to that previously seen with hepatic microsomal mixed function oxidase (MFO) activities with the identical protocol. Similarly, the metabolism of AFB₁ to AFQ₁ and AFM₁ was depressed by the 5% casein diets, with an increase in the production of chromatographically more polar material. The relationship of the MFO and epoxide hydrase activities to AFB₁ metabolism and formation of macromolecular adducts is discussed.     

An evaluation of kapok and Spanish moss bedding materials for mycotoxigenic potential using aspergillus flavus,A. parasiticus,and fusarium tricinctum

The potential of kapok and Spanish moss (used as fill materials in bedding manufacture) to support the production of aflatoxins (AFTs) and/or trichothecenes when inoculated with Aspergillus flavus, A. parasiticus, and Fusarium tricinctum isolates was evaluated. During incubation for 51 days at 23°C, all Spanish moss replicates supported the production of aflatoxins AFB₁ and AFG₁ and 90% supported trichothecene production (T-2 and HT-2 toxins). In 60% of the kapok replicates, production of AFB₁ and AFG₁ was supported, but none supported trichothecene production. In both materials, significantly more AFG₁ was produced than AFB₁ (P < 0·01). AFT production levels were significantly greater (P < 0·01) in Spanish moss in kapok, and ranged from 90 ng AFB₁g⁻¹ kapok to 839 ng AFB₁g⁻¹ Spanish moss and 221 ng AFG₁g⁻¹ kapok to 1376 ng AFG₁g⁻¹ Spanish moss. Spanish moss supported production of 15 271 ngT-2 toxin and 13 034 ng HT-2 toxin g⁻¹ Spanish moss.     

Effects of aflatoxin B, aflatoxin B, aflatoxin G and sterigmatocystin on viability, rates of development, and body length in two strains of Drosophila melanogaster (Diptera)

Two wild-type laboratory populations of Drosophila melanogaster, Florida-9 (sensitive to aflatoxin (AF) B₁-induced toxicity) and Lausanne-S (resistant to AFB₁-induced toxicity) were tested to determine relative degress of sensitivity to growth from the egg stage on media containing 0.2, 0.6, 2.0, and 4.0 ppm AFB₁, AFG₁, AFB₂, or sterigmatocystin (ST). Data indicate that strain Florida-9 is quite sensitive to AFG₁ toxicity at both the egg-pupa and egg-adult stages of development while Lausanne-S is quite resistant to such toxic effects. For Lausanne-S, AFB₁ > AFG₁ in relative toxicity, while for Florida-9, AFG₁ > AFB₁. The latter is noteworthy since vertebrate studies consistently show that AFB₁ is a significantly stronger carcinogen and mutagen than AFG₁. Possible explanations are discussed. Neither strain tested displayed toxic responses to the presence of AFB₂ or ST in the culture media; however, the 4.0-ppm Lausanne-S treatment displayed a significantly lower adult mortality rate than the control, indicating that Lausanne-S flies may benefit from the presence of ST in the culture medium.     

Panax ginseng extract modulates oxidative stress,DNA fragmentation and up-regulate gene expression in rats sub chronically treated with aflatoxin B1 and fumonisin B1

Aflatoxins and fumonisins are important food-borne mycotoxins implicated in human health and have cytotoxic effects. The aims of the current study were to evaluate the protective role of Panax ginseng extract (PGE) against the synergistic effect of subchronic administration of aflatoxin B₁ (AFB₁) and fumonisin B₁ (FB₁) on DNA and gene expression in rat. Female Sprague–Dawley rats were divided into eight groups (ten rats/group) and treated for 12 weeks including the control group, the group having received AFB₁ (80 µg/kg bw), the group having received FB₁ (100 µg/kg bw), the group having received AFB₁ plus FB₁ and the groups having received PGE (20 mg/kg bw) alone or with AFB₁ and/or FB₁. At the end of experiment, liver and kidney were collected for the determination of DNA fragmentation, lipid peroxidation (LP), glutathione (GSH) contents and alterations in gene expression. The results indicated that these mycotoxins increased DNA fragmentation, LP and decreased GSH content in liver and kidney and down-regulated gene expression of antioxidants enzymes. The combined treatments with AFB₁ and/or FB₁ plus PGE suppressed DNA fragmentation only in the liver, normalized LP and increased GSH in the liver and kidney as well as up-regulated the expression of GPx, SOD1 and CAT mRNA. It could be concluded that AFB₁ and FB₁ have synergistic genotoxic effects. PGE induced protective effects against their oxidative stress and genotoxicity through its antioxidant properties.     

Mutagenicity and cytotoxicity of the carcinogen-mutagen aflatoxin B1 in Streptococcus pneumoniae (Pneumococcus) and Salmonella typhimurium: dependence on DNA repair functions

Strains R6, R6x and R6uvr-1 of Streptococcus pneumoniae (Pneumococcus) are sensitive to the cytotoxic effects of the mutagen/carcinogen aflatoxin B₁ (AFB₁). R6uvr-1 is more prone to the cytotoxic effects of AFB₁ than the repair-proficient parental strain, R6. The same differential susceptibility of strains R6, R6x and R6uvr-1 was observed when UV light replaced metabolically activated AFB₁. All pneumococcal strains were immutable by AFB₁. AFB₁ mutagenesis in Salmonella typhimurium strains was dependent on a functional RecA gene product. The enhancing effects of ΔuvrB and plasmid pKM101 were found to be additive. Data presented are consistent with the following: (i) AFB₁ toxic effects are due mainly to DNA binding of AFB₁; (ii) AFB₁ mutagenesis is dependent on error-prone DNA repair; (iii) Pneumococcus lacks an active error-prone (SOS) DNA-repair system.     

In vivo covalent binding of aflatoxin B1 and aflatoxin M1 to liver DNA of rat,mouse and pig

[¹⁴C]Aflatoxin B₁ (AFB₁) was isolated from cultures of Aspergillus parasiticus grown on [1-¹⁴C]sodium acetate. Covalent binding of AFB₁ to liver DNA of rat and mouse was determined 6–8 h after oral administration. The effectiveness of covalent binding, expressed as DNA binding per dose in the units of a ‘Covalent Binding Index’ (CBI), (μmol aflatoxin/mol DNA nucleotides)/(mmol aflatoxin/kg animal), was found to be 10 400 for rats and 240 for mice. These CBI partly explain the different susceptibility of the two species for the incidence of hepatic tumors.The corresponding values for pig liver DNA, 24 and 48 h after oral administration, were found to be as high as 19 100 and 13 300. DNA-binding has not so far been reported for this species although it could represent an appropriate animal model for studies where a human-like gastrointestinal tract physiology is desirable.Aflatoxin M₁ (AFM₁) is a metabolite found in the milk of cows that have been fed AFB₁-contaminated diet. [¹⁴C]AFM₁ was also found to be produced by cultures of A. parasiticus giving a yield of about 0.3% of the total aflatoxins. A test for covalent binding to rat liver DNA revealed a CBI of 2100 showing that AFM₁ must also be regarded as a strong hepatocarcinogen. It is concluded that AFB₁ contaminations should be avoided in dairy feed.     

Study of aflatoxin B1 production by Aspergillus parasiticus in bee pollen of Greek origin

Aflatoxin B₁ (AFB₁) is a carcinogenic metabolite produced by certain Aspergillus species such as A. parasiticus and A. flavus. The beneficial properties of bee pollen have transformed this commodity into an increasingly frequent component of the human diet. As bee pollen is a substrate on which aflatoxigenic fungi can grow, AFB₁ production is likely. In the present study, we describe a method for aflatoxin B₁ determination in bee pollen utilising high pressure liquid chromatography (HPLC) with a fluorescence detector (FD). The recovery factor of the method was found to be 111% (RSD% 1.61), while the detection limit (LOD) was 0.08 ng AFB₁/g. An additional aim of this study was to investigate the growth of A. parasiticus and AFB₁ production in bee pollen. Results indicated that no mycelial growth was observed and no AFB₁ was detected in bee pollen samples containing natural microbiota throughout the entire observation period (20 days). In contrast, AFB₁ production in treated bee pollen samples (15 g pollen/flask) inoculated with A. parasiticus was significantly higher (p?≤?0.05) compared to control samples (treated but not inoculated) throughout the entire incubation period, while no mycelial growth was apparent. Maximum production was observed on the 12th day (79.29 ng AFB₁/flask and 32.44 ng AFB₁/flask for inoculated and non-inoculated bee pollen, respectively). As a result, AFB₁ production in bee pollen is likely even following a minor contamination, which could occur randomly.     

Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis

The interaction between phenolic compounds and the food-borne carcinogenic mycotoxin, aflatoxin B₁ (AFB₁), was examined. 6 phenolic compounds (gallic acid, chlorogenic acid, caffeic acid, dopamine, p-hydroxybenzoic acid and salicyclic acid) inhibited AFB₁-induced mutagenesis in Salmonella typhimurium strain TA98 in a suspension assay in the presence of rat-liver microsomes (S9). The inhibitory effect was observed when the phenolic compound and the mutagen (AFB₁ plus S9) were administered concurrently, but not when exposure to the mutagen was followed by the phenolic compound. The concentrations of the phenolic compounds used were not mutagenic to S. typhimurium strain TA98 and had no effect on the survival of the bacteria. The inhibition of AFB₁ metabolism was studied using high-pressure liquid chromatography. Increasing the concentration of all 6 phenolic compounds resulted in a dose-dependent reduction of both major AFB₁ metabolite peaks. The results are consistent with the hypothesis that (1) the phenolic compounds do not react covalently with AFB₁, and (2) the inhibitory effect of phenolic compounds on AFB₁-induced mutagenesis may be due to the inhibition of the activation enzymes.     

Aflatoxin B1 affects feed consumption in male rats through an action on the central nervous system

Aflatoxins (AFTs), secondary metabolites of the biodeteriogens Aspergillus flavus and A. parasiticus, include aflatoxin B₁ (AFB₁), which is hepatocarcinogenic, can cause cellular and tissue damage and because its chemical composition is similar to that of certain steroids, may exhibit some pathological activities similar to those of steroids. The latter can suppress feed consumption by acting upon the central nervous system. Here, is reported the results of an investigation designed to assess whether this biodeteriogen could alter either feed consumption or plasma glucose levels. Male Sprague-Dawley rats maintained for two weeks upon laboratory rat chow were subjected to either intracerebroventricular (ICV) or intravenous (IV) injections of both AFB₁ and estradiol. Both non-injected and carrier-injected (0·9% NaCl) animals served as controls. Following fasting for 21 h, the rats were provided with a weighed amount of feed and both feed consumption and plasma glucose levels quantified during the 22nd, 23rd and 24th hour. Both ICV injections of 10 and 100 ng AFB₁ and IV injections of 1 and 10 μg AFB₁ kg⁻¹ significantly (p < 0·01) suppressed daily feed intake, but did not affect plasma glucose levels. This supports the hypothesis that AFB₁ suppresses feed intake probably through action upon the central nervous system. If true, this action as well as the toxic and carcinogenic aspects, further support the need for the prevention and/or removal of the mycotoxin from food and feed.     

Lophirones B and C Extenuate AFB1‐Mediated Oxidative Onslaught on Cellular Proteins,Lipids, and DNA through Nrf‐2 Expression

The capability of lophirones B and C to extenuate aflatoxin B₁ (AFB₁)‐mediated onslaught on cellular proteins, lipids, and DNA was investigated for 6 weeks. Lophirones B and C significantly (P < 0.05) increase the expression and specific activity of cytoprotective enzymes (glutathione‐S‐trans‐ferase, nioctinamide adenine dicludeotide:quinone oxidoreductase‐1, epoxide hydrolase, and uridyl glucuronosyl transferase). There was significant (P < 0.05) reduction in the level of antioxidant system in AFB₁‐induced hepatocarcinogenesis. Furthermore, lophirones B and C significantly (P < 0.05) attenuated AFB₁‐mediated decrease in the specific activities of antioxidant enzymes. Oxidative stress biomarkers, malondialdehyde, lipid hydroperoxides, conjugated dienes, protein carbonyl, and fragmented DNA were significantly (P < 0.05) elevated in AFB₁‐treated rats. Although lophirones B and C did not significantly (P < 0.05) alter these biomarkers, an AFB₁‐mediated increase in these biomarkers was significantly attenuated. Results obtained showed that lophirones B and C extenuate AFB₁‐mediated onslaught on cellular proteins, lipids, and DNA by enhancing nuclear erythroid–related factor‐2 expression.     

Sex-determined differential mortality of milkweed bugs, Oncopeltus fasciatus (hemiptera), to aflatoxins

Studies on the aflatoxins, toxic metabolites of Aspergillus flavus and A. parasiticus, have involved test systems ranging from cell cultures to laboratory animals. This work reports on the differential response by sex of Oncopeltus fasciatus to aflatoxin B₁ (AFB₁). Young adult milkweed bugs were chosen randomly from our stock colony and housed in glass culture jars. Triplicate sets of experimental animals were fed 5 μg/ml of AFB₁ in their liquid diet. The first death for the experimental females occurred at day 4, and at 10 days for the experimental males. A 50% lethality level for experimental females developed by day 8. Males subjected to the same concentration achieved a 50% lethality level at day 24. For the females the LD₅₀ occurred after consuming 0.49 μg/ml of AFB₁. The results indicate that adult female milkweed bugs were hypersensitive to AFB₁ as compared to adult males. This organism is more sensitive than the American cockroach and less sensitive than the fruitfly, housefly, and honeybee to toxic aflatoxicosis. Even the female is not sufficiently sensitive to rate highly as a bioassay organism for AFB₁. The extreme difference in mortality between the sexes is significant, unusual, and unexplained.     

Effects of aflatoxin B1 and caffeine on viability in natural strains of Drosophila melanogaster

Thirty-five natural populations of Drosophila melanogaster from Virginia were tested for their degree of sensitivity to the carcinogen Aflatoxin B₁ (AFB₁) and to caffeine. Significant variations in sensitivity to each was demonstrated among these strains, but no correlation existed for relative degrees of sensitivity to AFB₁ or caffeine when strains were compared, although most strains were more severely affected by AFB₁. Eight of these strains were tested for the effects of simultaneous administration of AFB₁ and caffeine. Generally, caffeine demonstrated both a significant protective effect in preventing the high degree of egg-adult mortality produced by AFB₁ alone and a retardation of the significant decrease in body length shown by adults which survive in the AFB₁ treatments.     

Consequence of aflatoxin B1 ingestion on the membrane-bound liver endoplasmic reticulum Ca2+-ATPase of protein-undernourished Fischer F344 rats

Ingestion of the mycotoxin Aflatoxin B₁ (AFB₁) by protein-undernourished Fischer F344 rats for twelve weeks resulted in significant (p<0.05) increases in the proliferation of liver cells, reduced body weight and increased microsomal Ca²⁺-ATPase activity. Cyt. P₄₅₀ content, -Glutamyl Transferase (GGT) and Glutathione Transferase (GST) activities were unaffected. The ingestion of AFB₁ by normal rats had no effect on all the parameters investigated. It appears that the microsomal Ca²⁺-pumping ATPase of Protein-Undernourished (PU) Fischer F344 rats is more sensitive to the mycotoxin AFB₁ than its counterpart in well-nourished rats. The use of PU rat as animal model for studies on AFB₁ toxicity, particularly the effect of AFB₁ on the regulation of intracellular calcium ion concentration ([Ca²⁺]_i), is suggested.     

Immunosuppressive effects of aflatoxin in growing rats

The immunosuppressive potential of aflatoxin B₁ (AFB₁), the carcinogenic metabolite ofAspergillus flavus, was evaluated in growing rats. The weanling rats were subchronically exposed to 60, 300 and 600 µg AFB₁/kg body weight for four weeks on alternate days by oral feeding. Various parameters of cell mediated immunity (CMI) and humoral immunity were assessed in control and treated animals. CMI was evaluated by measuring delayed type of hypersensitivity (DTH) response and humoral by plaque forming cell (PFC) assay. The lymphoproliferative response assay for T- and B-cells was also performed. It was observed that AFB₁ selectively suppressed cell mediated immunity in growing rats. AFB₁ suppressed CMI at the 300 and 600 µg dose levels only as measured by DTH response assay. It is concluded that continuous low level exposure of aflatoxin to growing host may enhance its susceptibility to infection and tumorigenesis.Abbreviations AF Aflatoxin - AFB₁ Aflatoxin B₁ - CMI Cell mediated immunity - CPM Counts per minute - DTH Delayed type of hypersensitivity - GST Glutathione-S-transferase - LPS Lipopolysaccharide - PFC Plaque forming cell - PHA Phytohemagglutinin - SRBC Sheep red blood cells     

Error-prone Replication Bypass of the Primary Aflatoxin B1 DNA Adduct,AFB1-N7-Gua

Hepatocellular carcinomas (HCCs) are the third leading cause of cancer deaths worldwide. The highest rates of early onset HCCs occur in geographical regions with high aflatoxin B₁ (AFB₁) exposure, concomitant with hepatitis B infection. Although the carcinogenic basis of AFB₁ has been ascribed to its mutagenic effects, the mutagenic property of the primary AFB₁-DNA adduct, AFB₁-N7-Gua, in mammalian cells has not been studied extensively. Taking advantage of the ability to create vectors containing a site-specific DNA adduct, the mutagenic potential was determined in primate cells. This adduct was highly mutagenic following replication in COS-7 cells, with a mutation frequency of 45%. The spectrum of mutations was predominantly G to T base substitutions, a result that is consistent with previous mutation data derived from aflatoxin-associated HCCs. To assess which DNA polymerases (pol) might contribute to the mutational outcome, in vitro replication studies were performed. Unexpectedly, replicative pol δ and the error-prone translesion synthesis pol ζ were able to accurately bypass AFB₁-N7-Gua. In contrast, replication bypass using pol κ was shown to occur with low fidelity and could account for the commonly detected G to T transversions.     

Hepatic microsomal mixed function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites

Microsome-mediated metabolic activation of aflatoxin B₁ (AFB₁) and benzo[a]-pyrene (BP), as determined by the $\text{in vitro}$ formation of DNA binding metabolites, was studied, using hepatic microsomes from untreated, phenobarbital (PB)-treated and 3-methylcholanthrene (MC)-treated male rats. Contrasting results were obtained for the two substrates: in the case of AFB₁, microsomes from PB-treated rats were twice as active as microsomes from untreated and MC-treated rats, whereas, in the case of BP, microsomes from MC-treated rats were several fold more active than microsomes from untreated and PB-treated rats. These data strongly suggests enzyme multiplicity of microsomal mixed function oxygenase for the activation of carcinogens, especially AFB₁ and BP whose reactive metabolites are believed to be epoxides.     

Inhibition of in vitro aflatoxin B1-DNA binding in rainbow trout by CYP1A inhibitors: α-naphthoflavone, β-naphthoflavone and trout CYP1A1 peptide antibody

Rainbow trout cytochrome P450 (CYP)1A detoxifies aflatoxin B₁ (AFB₁) to aflatoxin M₁ (AFM₁), whereas CYP2K1 activates AFB₁ to AFB₁-8,9-epoxide. We report that α-naphthoflavone (ANF) and β-naphthoflavone (BNF) both strongly inhibit CYP1A-mediated ethoxyresorufin O-deethylase (EROD) activity (K_i = 9.1 ± 0.8 and 7.6 ± 1.1 nM, respectively). These inhibitors (selective for mammalian CYP1A at low concentrations), as well as rabbit polyclonal antibody to a trout CYP1A1 peptide (residues 277–294), also strongly inhibited trout microsome-catalyzed AFB₁-DNA binding and lauric acid (ω-1) hydroxylation in vitro, reactions previously established to be CYP2K1-dependent. ANF at 0.5, 5, 50 and 500 μM inhibited liver microsome-catalyzed AFB₁-DNA binding by 22, 58, 84 and 91%, respectively, whereas BNF at the same concentrations inhibited 22, 74, 78 and 81%, respectively. The CYP1A1 peptide and CYP2K1 polyclonal antibodies (10 mg IgG/mg microsomal protein) inhibited AFB₁-DNA binding by 84 and 66%, respectively, compared with pre-immune IgG. Lauric acid (ω-1) hydroxylation was inhibited 61% by 5 μM ANF, 69% by 5 μM BNF and 100% by either antibody at 12 mg IgG/mg microsomal protein. These results demonstrate that mammalian CYP1A inhibitors also inhibit trout microsomal AFB₁-DNA binding and lauric acid (ω-1) hydroxylation, catalyzed primarily by CYP2K1. In the absence of evidence that trout CYP1A can catalyze AFB₁-DNA binding, the results suggest configuration similarities at, or near, the active sites for these two fish enzymes that result in antibody crossreaction and loss of the inhibitor specificity observed with mammalian CYP1A.     

Prevention of cardiotoxicity of aflatoxin B1 via dietary supplementation of papaya fruit extracts in rats

The aim of the current study was to evaluate the cardioprotective ability of water (WE) and ethanolic (EE) papaya fruits extracts against cardiotoxicity induced by aflatoxin B₁ (AFB₁) in rats. Forty two female Sprague–Dawley rats were divided into six treatment groups and treated orally for 2 weeks as follow: control group, the group treated with WE (250 mg/kg b.w), the group treated with EE (250 mg/kg b.w), the group treated orally with AFB₁ (17 μg/kg b.w) and the groups treated orally with AFB₁ plus WE or EE. The results indicated that treatment with AFB₁ resulted in oxidative stress in the heart manifested by the marked increase in cardiac malondialdehyde and calcium levels accompanied with a significant decrease in cardiac total antioxidant capacity. Serum nitric oxide and sodium levels, lactate dehydrogenase and creatine kinase isoenzyme activities were significantly increased, whereas, cardiac Na⁺/K⁺-ATPase activity and serum potassium were insignificantly affected. Supplementation with WE or EE effectively ameliorated most of the changes induced by AFB₁. It could be concluded that both extracts attenuated the oxidative stress induced in heart tissue by AFB₁ and WE was more pronounced due to the higher total phenolic contents than in the EE.     

HPLC based method for the measurement of the reduction of aflatoxin B<Subscript>1</Subscript> by bacterial cultures isolated from different African foods

The consumption of fermented foods contaminated with aflatoxin B₁ is linked to aflatoxicosis. Aflatoxicosis is a serious problem in developing countries with environmental conditions appropriate for the biosynthesis of AFB₁ byAspergillus flavus andAspergillus parasiticus. In Africa, especially in Ghana and Nigeria, there is a very high risk of liver cancer which is caused by the consumption of AFB₁-intoxicated, traditionally fermented maize and sorghum products. It is suggested that one way to diminish this health risk might be the reduction of the AFB₁ concentration in foods by bacteria. Especially bacteria used for food fermentation processes are of great importance, with a special emphasis on lactic acid bacteria which are involved in traditionally fermented African foods based on maize and sorghum.Most publications dealing with aflatoxin degradation by microorganisms describe a phosphate buffer test system for the performance of degradation experiments. In contrast to that, a test system based on physiological active bacterial and yeast cells has been developed, to assess food fermentation organisms for their ability to reduce the AFB₁ concentration in vitro. The aflatoxin B₁ concentration in test samples was quatitatively determined by HPLC.The assessment of lactic acid bacteria originating from different German and other European culture collections only showed a very slight reduction of the AFB₁ concentration from 3% to 12%. Screening experiments in which other bacterial genera and lactic acid bacteria, isolated from different African foods have been assessed, in most cases showed the same results. However, some bacterial strains, e.g. strains of the genusBacillus derived from European culture collections and strains of the genusLactobacillus isolated from African foods, caused a release of AFB₁ which was chemically bound before to components of the test medium and which therefore could not be extracted with chloroform.A process quite similar to that may happen during food fermentations. Different experiments showed that e.g. cellulose can bind AFB₁ very effectively. Cellulose and different other food components are well known to absorb AFB₁. During fermentation the cellulose and other AFB₁-absorbing components may be degraded and the AFB₁ will be released again.The only bacterial strain known as yet which is able to reduce the AFB₁ concentration in vitro and in different food comodities isNocardia corynebacteroides (formerFlavobacterium aurantiacum). Nevertheless the mechanism of this AFB₁ reduction is actually not well understood, it still has to be investigated. In the meantime several other bacterial strains, presumably from the taxonomic group of theActinomycetes could be proved to be effective reducers of the AFB₁ concentration in our in vitro test system. Because as yet no food relevant microorganism could be found, which is able to degrade AFB₁, these new strains in general offer the possibility for a genetic modification of food relevant microorganisms. This seems to be the way to come to starter cultures which are able to degrade AFB₁ during food fermentations.